MRS. YEKATERINA S. NOBLE APN-CNP
Prescription History 1891404521
Nurse Practitioner in Huntley, IL

Active since November 21, 2022PECOS EnrolledAccepts Medicare Assignment
93.08/100
CMS Quality Rating
10350 HALIGUS RD STE A, HUNTLEY, IL 60142(815) 338-6600(847) 802-7162 Get Directions

NPPES record last updated: June 21, 2024. Verified against the NPPES registry weekly; last sync: July 19, 2026.

Record update history: Jun 21, 2024, Jan 31, 2023, Nov 21, 2022 (3 updates tracked since 2022).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. YEKATERINA S. NOBLE APN-CNP, an active Nurse Practitioner specialist practicing in Huntley, IL. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 14 documented patient claims. Among these therapy options, the most frequently utilized medication is Paxlovid (Eua), which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
14
Total Claims
14
30-Day Fills
Paxlovid (Eua)
Most Prescribed · 14 claims
View details
1 medication · 2023 Medicare Part D
Medicare Part D medications prescribed by MRS. YEKATERINA S. NOBLE APN-CNP in 2023, with claim volumes, costs, and IL state comparisons
Medication Claims 30-Day Fills Days Supply Cost / Claim Utilization vs IL Avg
Paxlovid (Eua)Nirmatrelvir/Ritonavir1414.070$9.79▼ below IL avg Below Avg.

Utilization: claims vs the average IL prescriber

This provider
14
IL average
23.0

Averages are among IL prescribers of this medication. Utilization reflects practice size as well as clinical preference.

Cost per claim: this provider vs the IL average

This provider
$9.79
IL average
$10.68

This provider's average cost per claim is below the IL average for this medication.

14.0
30-Day Fills
70
Days Supply

About Paxlovid (Eua): The combination of nirmatrelvir tablets and ritonavir tablets is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾

The product is also approved to be used in Canada to treat COVID-19. It is used by people who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with nirmatrelvir and ritonavir. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases (boosts) the levels of nirmatrelvir. This helps nirmatrelvir work better. More information about nirmatrelvir and ritonavir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use and from the Health Canada Patient Medication Information sheet. There is limited information about how safe and effective the combination of nirmatrelvir and ritonavir is for treating COVID-19. Study results show that nirmatrelvir and ritonavir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of nirmatrelvir and ritonavir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions.

No medications match the current filters.
Above Avg. Typical Below Avg.= utilization vs the average IL prescriber of the same drug; volume reflects practice size as well as clinical preference.Green cost= below the IL average cost per claim.

About this data. The prescription history for MRS. YEKATERINA S. NOBLE APN-CNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Huntley, IL practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IL prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.